Patient webinars: Covid-19 and cardiac sarcoidosis

In the coming months, we will be hosting a series of webinars to give patients the opportunity to hear from members of our cardiac sarcoidosis team as they discuss Covid-19 and what this may mean for patients. Patients will also have the opportunity to ask questions and raise any concerns.


Past webinars

Topic: Covid-19 and cardiac sarcoidosis

On 10th Feb the cardiac sarcoidosis team hosted a webinar for patients, exploring a range of topics, including challenges in diagnosis, management and monitoring of cardiac sarcoidosis during the Covid-19 era, the vaccination programme and efficacy for cardiac sarcoidosis patients, and how we are delivering care for cardiac sarcoidosis patients at the current time.

You can watch a recording of the webinar here.


Topic: Challenges and implications of Covid-19 for people living with cardiac sarcoidosis

On 1st July the cardiac sarcoidosis team hosted their first webinar for patients to explore the challenges and implications of Covid-19 for people living with the condition. The session explored a range of issues including the challenges in diagnosis, management and monitoring of cardiac sarcoidosis during the Covid-19 era, and a discussion around whether patients with the condition are at higher risk of the disease. Patients also had the opportunity to ask the clinical team questions.

You can watch a recording of the session here

Agenda

Session 1 – Diagnostic evaluation and the treatment of cardiac sarcoidosis prior to the Covid-19 era

  • Welcome
  • Screening for cardiac sarcoidosis
  • Multi-disciplinary diagnosis of cardiac sarcoidosis including clinical and imaging perspectives
  • Treatment of cardiac sarcoidosis – immunosuppression and cardiac therapy/devices

Session 2 – Challenges in diagnosis, management and monitoring of cardiac sarcoidosis during the Covid-19 era

  • Are patients with cardiac sarcoidosis at a higher risk of Covid-19 infection?
  • Changes to the diagnostic approach in cardiac sarcoidosis
  • Changes in the management of cardiac sarcoidosis

Session 3 – Patient engagement

  • A personal experience during lockdown
  • Experience of new cardiac sarcoidosis diagnosis during Covid-19 infection
  • Update from SacoidosisUK Team
  • Questions from patients

Speakers

  • Dr John Baksi, consultant cardiologist 
  • Dr Rajdeep Khattar, consultant cardiologist 
  • Dr Vasileios Kouranos, consultant respiratory physician 
  • Dr Rakesh Sharma, clinical lead for heart failure   
  • Dr Kshama Wechalekar, consultant in nuclear medicine  
  • Professor Athol Wells, head of the interstitial lung disease unit.  

Share